Menstrual & Hormonal Health
Heavy Periods, Iron Deficiency, and Cycle-Linked Joint Pain in Hypermobility
We're not doctors. What's below is a summary of published research on heavy menstrual bleeding, iron levels, and cycle-linked joint symptoms in hEDS/HSD, gathered so you have something specific for a doctor's appointment rather than a general impression.
This is a page where it matters to separate what's actually been studied in hEDS from what's a reasonable-sounding extension of research done in other groups. Some of what follows is solid and specific to hEDS. Some of it is general research being cautiously applied to hEDS because the hEDS-specific study hasn't been done yet. We'll say which is which.
Heavy Menstrual Bleeding and Iron Deficiency in hEDS
Heavy menstrual bleeding, or menorrhagia, is well documented in hEDS. A cohort study of 386 women with hEDS found it in 76% of participants. A newer study of 52 patients found it in 88%, and within that group, half had bleeding severe enough to require an ER visit, a transfusion, or surgery. This is an underappreciated part of the hEDS picture: heavy periods are common enough, and severe enough for a meaningful share of patients, that it deserves to be treated as a real clinical issue rather than something to just push through.
The two studies drew on different cohorts and different sample sizes, yet both landed in the same range: 76% and 88%. That consistency is part of why the finding carries weight, more than a single study alone would show, even though neither study establishes a specific biological mechanism for why connective tissue laxity would drive heavier bleeding.
Where the Hormone-Hypermobility Evidence Is Weaker
Given how common heavy bleeding is, iron deficiency seems like a logical next step. But no peer-reviewed study has directly measured how common iron or ferritin deficiency actually is in hEDS specifically, and none has tested iron repletion against hEDS symptoms specifically. That gap is real and worth naming rather than papering over.
What does exist is a placebo-controlled trial in iron-deficient, fatigued women generally, not an hEDS-specific population: IV iron reduced fatigue in 65.3% of participants compared to 52.7% on placebo. That's a real, moderate effect in the population it was tested in. Applying it to hEDS is a reasonable hypothesis given how much menorrhagia shows up in this group, but it's an extension of general evidence, not a finding proven in hEDS patients.
Cycle-Linked Joint Laxity and Menopause: Fact vs. Myth
General-population research shows joint laxity shifts across the menstrual cycle, driven by estrogen and relaxin. Whether that pattern holds in hEDS the same way is unconfirmed: no controlled trial in this population has tested it, so treat this as a plausible extension of outside research, not a proven finding here.
One claim circulating widely deserves a direct correction: the figure that 61% of hEDS patients report symptoms worsening after menopause is not from peer-reviewed research. It traces back to a patient blog survey. The actual peer-reviewed data, from the same 386-woman cohort cited above, found 22% reported improvement after menopause. That doesn't support a clean story in either direction, worse or better, and the honest thing to do is say so rather than repeat the more dramatic number because it's more widely shared.
What to do with this
If your periods are heavy enough to soak through protection quickly, require you to plan your life around them, or have ever needed emergency treatment, that's worth a gynecology referral on its own. Menorrhagia in hEDS is common and clinically significant, not something to normalize as 'just how periods are for you.'
If fatigue is also part of the picture, ask about ferritin and iron testing rather than starting any supplement on your own. Supplementation only makes sense if a test shows you're actually deficient, and dosing needs medical guidance either way. If you notice your joint pain or laxity shifting with your cycle, or your symptoms changing around menopause, that's useful information to describe to your doctor, but it isn't yet something research has confirmed follows a fixed pattern in hEDS. Hormonal treatments like contraception or HRT help some patients and worsen things for others, so any decision there belongs in a conversation with a doctor who knows your history, not a generic recommendation.
Sources referenced on this page
- 01Cohort study, n=386 women with hEDS: menorrhagia prevalence (76%) and post-menopause symptom change (22% improved)
- 02Cohort study, n=52 hEDS patients: menorrhagia prevalence (88%), severity requiring ER/transfusion/surgery in 50%
- 03Placebo-controlled trial, iron-deficient fatigued women (general population): IV iron vs. placebo effect on fatigue (link not yet sourced)
- 04General-population research on menstrual-cycle-linked joint laxity via estrogen/relaxin mechanisms (not hEDS-specific) (link not yet sourced)
- 05Note: the widely cited '61% worsen after menopause' figure traces to a patient blog survey, not peer-reviewed research (link not yet sourced)